Company intelligence / Profile preview

Jumpstart

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Jumpstart Fertility is developing NAD+ precursor small-molecule therapies that have shown preclinical efficacy in rescuing fertility and improving oocyte quality in aged and chemotherapy-treated animal models; there is no evidence yet of clinical-stage human trials.[1][10]

Therapeutic areas: Women's Health
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Jumpstart.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jumpstart.

Explore the full profile